Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease

ABSTRACT Background  Autosomal dominant polycystic kidney disease (ADPKD), which is caused by mutations in polycystins 1 (PC1) and 2 (PC2), is one of the most commonly inherited renal diseases, affecting ~1 : 1000 Caucasians. Materials and methods  We screened Greek ADPKD patients with the denaturin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical investigation 2008-03, Vol.38 (3), p.180-190
Hauptverfasser: Dedoussis, G. V. Z., Luo, Y., Starremans, P., Rossetti, S., Ramos, A. J., Cantiello, H. F., Katsareli, E., Ziroyannis, P., Lamnissou, K., Harris, P. C., Zhou, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Background  Autosomal dominant polycystic kidney disease (ADPKD), which is caused by mutations in polycystins 1 (PC1) and 2 (PC2), is one of the most commonly inherited renal diseases, affecting ~1 : 1000 Caucasians. Materials and methods  We screened Greek ADPKD patients with the denaturing gradient gel electrophoresis (DGGE) assay and direct sequencing. Results  We identified a patient homozygous for a nucleotide change c.1445T > G, resulting in a novel homozygous substitution of the non‐polar hydrophobic phenylalanine to the polar hydrophilic cysteine in exon 6 at codon 482 (p.F482C) of the PKD2 gene and a de‐novo PKD1 splice‐site variant IVS21–2delAG. We did not find this PKD2 variant in a screen of 280 chromosomes of healthy subjects, supporting its pathogenicity. The proband's parents did not have the PKD1 mutation. Real‐time PCR of the PKD2 transcript from a skin biopsy revealed 20‐fold higher expression in the patient than in a healthy subject and was higher in the patient's peripheral blood mononuclear cells (PBMCs) than in those of her heterozygote daughter and a healthy subject. The greater gene expression was also supported by Western blotting. Inner medullar collecting duct (IMCD) cells transfected with the mutant PKD2 mouse gene presented a perinuclear and diffuse cytoplasmic localization compared with the wild type ER localization. Patch‐clamping of PBMCs from the p.F482C homozygous and heterozygous subjects revealed lower polycystin‐2 channel function than in controls. Conclusions  We report for the first time a patient with ADPKD who is heterozygous for a de novo PKD1 variant and homozygous for a novel PKD2 mutation.
ISSN:0014-2972
1365-2362
DOI:10.1111/j.1365-2362.2007.01913.x